Programmed cell death has seemed to be regulated in quite different ways in mammals and Drosophila. Recent results on the way Ras and downstream pathways can influence cell-death induction suggest the regulatory pathways in these distinct organisms might be more similar than was at first sight apparent.
Programmed cell death, or apoptosis, is a critical factor in homeostasis in all multicellular organisms, playing a crucial role in removing excess unwanted cells without stimulation of an immune response. In order to minimise the risk of cells proliferating in an uncontrolled manner, apoptosis is thought to act as a 'default programme' for metazoan cells, which has to be suppressed at all times by the action of survival signals. Some progress has been made in understanding at the molecular level how survival signals impact on the control of apoptosis in mammalian cells in the past couple of years; now, two groups [1, 2] have used genetic approaches in Drosophila to determine how the fly homologue of the Ras oncogene suppresses apoptosis during the formation of the compound eye.
Most of our current understanding of apoptosis has emerged from parallel molecular and cell biological studies in mammalian systems and developmental genetic analyses in the nematode worm Caenorhabditis elegans. In the worm, 131 of a total of 1090 cells in the organism die by suicide in a predictable manner. Three genes play a critical role in the regulation of this cell death, the pro-apoptotic ced-3 and ced-4 genes, and antiapoptotic ced-9 gene [3] . These three players correspond to three families of key death regulators in the mammalian system: ced-3 encodes a caspase, the cysteineaspartate directed proteases that are responsible for dismembering key cellular proteins, as well as being early components of the signalling pathway for induction of apoptosis. The product of ced-4 is an adaptor protein, the mammalian homologue of which is Apaf1, which controls activation of caspases, particularly by cytochrome c released from mitochondria. And ced-9 encodes a homologue of Bcl-2, the protective factor which is overexpressed in some tumours and which prevents activation of executioner caspases via Apaf1.
Most of the apoptosis-regulating factors found in mammals are also in place in worms, although the mammalian system has enormously greater complexity, with large families of caspases and Bcl-2-related proteins. The only major players in cell-death regulation in mammals that have not been found in worms are the death receptors, such as Fas/CD95 and tumour necrosis factor receptor I, and their associated adaptors, such as FADD and TRADD.
In the mammalian system, there has been much interest recently in how growth factors and activated oncogenes are able to suppress apoptosis. For example, many factors that protect cells from apoptosis are able to stimulate the activity of the lipid kinase, phosphoinositide 3-OH kinase (PI 3-kinase). The lipids produced by this enzyme stimulate the activity of the protein kinase Akt, also known as protein kinase B (PKB) [4] . This kinase is able to phosphorylate and neutralise Bad, a pro-apoptotic member of the Bcl-2 family that blocks Bcl-2 function by heterodimer formation; Akt phosphorylation of Bad prevents its binding to Bcl-2. Akt has also been reported to phosphorylate and inactivate caspase-9 [5] . Another commonly used anti-apoptotic signalling system in mammals involves NF-κB, which again is activated in response to a wide range of protective factors. Unlike the Akt pathway, which appears to be largely independent of transcriptional regulation, NF-κB acts by altering transcription of responsive genes, in particular inducing the expression of certain anti-apoptotic proteins such as the 'inhibitor of apoptosis proteins' (IAPs) [6] .
The ability of some activated oncogenes to protect tumour cells from apoptosis is likely to be very important in promoting the disordered growth of these cells in the absence of survival factors that is characteristic of cancer. The mutationally activated ras oncogene, commonly found in human tumours, has been shown to be able to protect cells from apoptosis in some contexts, but also to induce apoptosis in others. The response is partly dependent on the cell type being studied, but also reflects Ras's ability to activate multiple signalling pathways directly at the same time. Through its interaction with the protein kinase Raf, Ras can activate the mitogen-activated protein (MAP) kinase pathway, and through interaction with the catalytic subunit of PI 3-kinase it can activate Akt [7] . The Akt pathway has only ever been shown to have anti-apoptotic consequences, but the MAP kinase pathway can be pro-apoptotic under some conditions. The complexity, context-dependence and lack of clarity in this signalling network can be disheartening; it is likely, however, that at least some of this complexity is artifactual and reflects the non-physiological nature of the experimental systems used, which may involve high levels of overexpression of components, or the use of cell lines that have undergone numerous other, usually unknown, genetic changes.
The impact of Ras on cell death regulation has been crying out for new experimental approaches. Now Kurada and White [1] and Bergmann et al. [2] have turned the power of Drosophila genetics towards analysing the influence of Ras in the control of apoptosis in the fly eye. The picture that emerges holds several surprises and implies that a number of pieces may still be missing from our picture of the mammalian death-regulatory system. Studies of apoptosis in Drosophila have revealed a number of familiar components, such as caspases and IAPs, but many of the players essential in vertebrate and worm apoptosis, such as Bcl-2 proteins or death receptors, have not been found in Drosophila. Instead, three novel genes, reaper, grim and hid, have been shown to be essential for most normal apoptosis in Drosophila -without them, normal apoptosis in embryonic development does not occur and the embryos die [8] . Homologues of these genes have not been found in the vertebrate or worm systems. So is cell death in Drosophila entirely different from that in other systems?
One clue to the roles these genes play may be found in their expression patterns. Thus, grim and reaper expression is restricted to those cells that will die, whereas hid is expressed both in doomed cells and in cells that will survive. Ectopic expression of any of these genes results in excess cell death. The recent papers by Kurada and White [1] and Bergmann et al. [2] use this observation to identify other genes that may function together with these 'death' genes. Both groups used ectopic death-gene expression in the fly eye to induce apoptosis, and screened for dominant suppressors or enhancers of this cell death. They both found that activation of the Ras/MAP kinase pathway inhibits cell death controlled by this complex of genes. of a number of negative regulators of Ras activity. Both groups found that activated Ras strongly inhibits the death caused by ectopic expression of hid, although only Kurada and White [1] saw an effect of Ras on reaper-induced death. In contrast, the cell death induced by ectopic expression of grim was found not to be affected by Ras, suggesting grimmediated cell death lies in a separate pathway.
Kurada and
One of the major pathways downstream of Ras is the MAP kinase cascade, so both groups looked for effects of components of this cascade on the induced cell death. They found that loss of MAP kinase components enhanced cell death, whereas their overexpression or activation inhibited cell death. Activators of the Ras/MAP kinase pathway, such as epidermal growth factor (EGF), were also found to inhibit cell death. But how does the Ras/MAP kinase pathway inhibit the cell death otherwise induced by Hid and Reaper? Hid is clearly inhibited by activated Ras/MAP kinase, but slightly different mechanisms are proposed for how this occurs.
Kurada and White [1] focussed their attention on the control of hid expression, and found that activation of the Ras/MAP kinase pathway led to a decrease in hid mRNA level. Looking downstream of MAP kinase, they found that two transcriptional targets of Ras in the eye, pnt and yan, encode proteins that can also affect hid expression. Pnt, a positive effector of the Ras pathway, was found to downregulate hid transcript levels, whereas a negative effector, Yan, was found to upregulate hid expression and thereby induce cell death in the embryo. So it looks as though Ras is acting through the same pathway -involving MAP kinase, Pnt and Yan -both to induce differentiation and to inhibit cell death.
Bergmann et al. [2] concentrated on the control of Hid activity. Hid protein contains MAP kinase consensus sites, making it a likely target for phosphorylation. To test if these putative MAP kinase sites are important, they substituted these residues by non-phosphorylatable amino acids. This was expected to yield mutant forms of Hid resistant to inactivation by MAP kinase and indeed, in tissue culture assays and in vivo, the Hid mutants turned out to be 'superkillers' which are resistant to Ras inactivation. It thus appears likely that Hid is regulated by the Ras/MAP kinase pathway, both at the level of protein phosphorylation and at the level of gene expression.
How different are the cell death pathways in mammals and flies? At first sight, it appears that apoptosis is controlled quite differently in flies than in mammals. Hid, Grim and Reaper have not been found in worms or mammals, and upstream components such as Ced-9/Bcl-2 and death receptors have not been found in flies. As these new papers [1, 2] indicate, however, there is a similarity in the way Ras acts to prevent apoptosis in these phylogenetically distinct organisms (Figure 1 ). In flies, the major survival signalling pathway downstream of Ras in the eye is the Raf/MAP kinase branch, which is not always protective in mammals [7] . But the evidence reported by Bergmann et al. [2] suggests that the PI 3-kinase/Akt branch of the Ras pathway also contributes to the anti-apoptotic effects of Ras in flies, as in vertebrates, although in flies the effects are weaker than those of the Raf/MAP kinase branch.
There are other similarities between the cell-death machinery in flies and mammals. Thus, Drosophila caspases, such as drICE [9] and Dcp-1 [10] , have been identified and shown to function in cell death. Another similarity is that the loss of Drosophila Akt1 results in ectopic cell death [11] . In addition, some components that have only been found in one system or the other can function in the heterologous system. The C. elegans genes ced-3 and ced-9, when expressed in transfected Drosophila cells, act in a similar manner as they do in C. elegans [12] . Mammalian Fas can also induce cell death in Drosophila cells [13] . Conversely, Reaper and Grim can induce cell death in mammalian cells [14] and can bind human IAPs, which inhibit their ability to induce cell death.
Might mammalian homologues of Grim, Hid and Reaper exist after all? An apparent vertebrate target of Reaper has recently been identified. This is Scythe, a protein found in Xenopus egg extracts that interacts directly with Reaper and apparently mediates its induction of cytochrome c release from mitochondria and consequent caspase activation in vitro [15] . This suggests that true vertebrate homologues of Reaper are likely to exist. Furthermore, there might be other cell death pathways in the fly that have not yet been characterised: apoptosis is an essential part of Drosophila oogenesis, yet this particular cell death has been shown to proceed normally in flies lacking Grim, Hid and Reaper [16] . So perhaps homologues of other mammalian death regulators are important in regulating the apoptotic cell death in Drosophila oogenesis. While it is still possible that fly cells die in very different ways than those of mammals or worms, things might turn out not to be so different after all.
